Ermengol Coma
Impact in
- Modeling and Simulation top 5%
- COVID-19 epidemiological studies
- Epidemiology top 10%
- Respiratory viral infections research
- Pneumonia and Respiratory Infections
Papers in
- Epidemiology 13
- Respiratory viral infections research 8
- Data-Driven Disease Surveillance 3
-
- SARS-CoV-2 and COVID-19 Research 5
- COVID-19 Clinical Research Studies 3
- Co-authors
- Manuel Medina (26 shared papers)Francesc Fina (25 shared papers)Leonardo Méndez-Boo (20 shared papers)Eduardo Hermosilla (22 shared papers)Mireia Fàbregas (14 shared papers)Núria Mora (15 shared papers)Mència Benítez (9 shared papers)Carolina Guiriguet (9 shared papers)
- Journals
- The Lancet Regional Health - Europe (4 papers)BMC Family Practice (3 papers)Frontiers in Public Health (3 papers)BMJ Open (2 papers)BMC Infectious Diseases (2 papers)
- Partner nations
- SpainUnited KingdomUnited States
In The Last Decade
Ermengol Coma
43 papers receiving 711 citations
Ermengol Coma's Hit Papers
Peers
Comparison fields: 5 of 81
- Modeling and Simulation 45
- Epidemiology 231
- Infectious Diseases 120
- Health 34
- Oncology 98
Countries citing papers authored by Ermengol Coma
This map shows the geographic impact of Ermengol Coma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ermengol Coma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ermengol Coma more than expected).
Fields of papers citing papers by Ermengol Coma
This network shows the impact of papers produced by Ermengol Coma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ermengol Coma. The network helps show where Ermengol Coma may publish in the future.
Co-authors
The 25 scholars most cited alongside Ermengol Coma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 93 | |
| 2 | 2021 | 60 | |
| 3 | Effectiveness of nirsevimab immunoprophylaxis against respiratory syncytial virus-related outcomes in hospital and primary care settings: a retrospective cohort study in infants in Catalonia (Spain) Hit paper breakdown → | 2024 | 57 |
| 4 | 2021 | 49 | |
| 5 | 2022 | 42 | |
| 6 | 2008 | 41 | |
| 7 | 2014 | 32 | |
| 8 | 2021 | 28 | |
| 9 | 2019 | 28 | |
| 10 | 2013 | 23 | |
| 11 | 2020 | 22 | |
| 12 | 2022 | 22 | |
| 13 | 2012 | 21 | |
| 14 | 2022 | 19 | |
| 15 | 2022 | 16 | |
| 16 | 2013 | 15 | |
| 17 | 2021 | 15 | |
| 18 | 2024 | 12 | |
| 19 | 2021 | 11 | |
| 20 | 2020 | 11 |
About Ermengol Coma
Ermengol Coma is a scholar working on Epidemiology, Infectious Diseases, General Health Professions, Oncology and Clinical Psychology, having authored 48 papers that have together received 721 indexed citations. Recurring topics across this work include Respiratory viral infections research (8 papers), SARS-CoV-2 and COVID-19 Research (5 papers), COVID-19 and healthcare impacts (5 papers), Primary Care and Health Outcomes (3 papers), COVID-19 and Mental Health (3 papers), Data-Driven Disease Surveillance (3 papers), COVID-19 Clinical Research Studies (3 papers) and Infection Control and Ventilation (2 papers). The work is most often cited by research in Modeling and Simulation (45 citations), Epidemiology (231 citations), Infectious Diseases (120 citations), Health (34 citations) and Oncology (98 citations). Ermengol Coma has collaborated with scholars based in Spain, United Kingdom and United States. Frequent co-authors include Manuel Medina, Francesc Fina, Leonardo Méndez-Boo, Eduardo Hermosilla, Mireia Fàbregas, Núria Mora, Mència Benítez, Carolina Guiriguet, Daniel Prieto‐Alhambra and Carmen Cabezas. Their work appears in journals such as The Lancet Regional Health - Europe, BMC Family Practice, Frontiers in Public Health, BMJ Open and BMC Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.